Cargando…

Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma

Detalles Bibliográficos
Autores principales:	Nguyen, Hong Phuong, Le, Anh Quynh, Liu, Enze, Cesarano, Annamaria, DiMeo, Francesco, Perna, Fabiana, Kapur, Reuben, Walker, Brian A., Tran, Ngoc Tung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685262/ https://www.ncbi.nlm.nih.gov/pubmed/38035085 http://dx.doi.org/10.3389/fimmu.2023.1334733

Ejemplares similares

Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
por: Nguyen, Hong Phuong, et al.
Publicado: (2023)

Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma
por: Dong, Chuanpeng, et al.
Publicado: (2021)

Protein Arginine Methyltransferase 5 (PRMT5) has prognostic relevance and is a druggable target in Multiple Myeloma
por: Gullà, Annamaria, et al.
Publicado: (2017)

Protein arginine methyltransferase 6 is a novel substrate of protein arginine methyltransferase 1
por: Cao, Meng-Tong, et al.
Publicado: (2023)

Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
por: Hsu, Ming-Chuan, et al.
Publicado: (2019)

Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway
por: Palam, Lakshmi Reddy, et al.
Publicado: (2023)

The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
por: Zhou, Xun, et al.
Publicado: (2022)

Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor
por: Feoli, Alessandra, et al.
Publicado: (2023)

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
por: Vlummens, Philip, et al.
Publicado: (2022)

A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma
por: Di Meo, Francesco, et al.
Publicado: (2023)

Structural biology and chemistry of protein arginine methyltransferases
por: Schapira, Matthieu, et al.
Publicado: (2014)

The Role of Protein Arginine Methyltransferases in Inflammatory Responses
por: Kim, Ji Hye, et al.
Publicado: (2016)

Protein Arginine Methyltransferases in Neuromuscular Function and Diseases
por: Lee, Jinwoo, et al.
Publicado: (2022)

Corrigendum: Schistosoma mansoni coactivator associated arginine methyltransferase 1 (SmCARM1) effect on parasite reproduction
por: Coelho, Fernanda Sales, et al.
Publicado: (2023)

The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation
por: Bai, Xuemei, et al.
Publicado: (2022)

Roles of Protein Arginine Methyltransferases in the Control of Glucose Metabolism
por: Han, Hye-Sook, et al.
Publicado: (2014)

Protein Arginine Methyltransferase 1 Methylates Smurf2
por: Cha, Boksik, et al.
Publicado: (2015)

Protein arginine methyltransferase expression and activity during myogenesis
por: Shen, Nicole Y., et al.
Publicado: (2018)

Structure, Activity and Function of the Protein Arginine Methyltransferase 6
por: Gupta, Somlee, et al.
Publicado: (2021)

Structure and Function of Protein Arginine Methyltransferase PRMT7
por: Halabelian, Levon, et al.
Publicado: (2021)

Role of Protein Arginine Methyltransferases and Inflammation in Muscle Pathophysiology
por: So, Hyun-Kyung, et al.
Publicado: (2021)

Protein arginine methyltransferases and hepatocellular carcinoma: A review
por: Lei, Yu, et al.
Publicado: (2021)

Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021)

The Role of Protein Arginine Methyltransferases in DNA Damage Response
por: Brobbey, Charles, et al.
Publicado: (2022)

The arginine methyltransferase Carm1 is necessary for heart development
por: Jamet, Sophie, et al.
Publicado: (2022)

Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies
por: Sauter, Camille, et al.
Publicado: (2022)

Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
por: Yan, Leilei, et al.
Publicado: (2014)

Theoretical Insights into Catalytic Mechanism of Protein Arginine Methyltransferase 1
por: Zhang, Ruihan, et al.
Publicado: (2013)

Crystal Structure of Arginine Methyltransferase 6 from Trypanosoma brucei
por: Wang, Chongyuan, et al.
Publicado: (2014)

Functional interplay between protein arginine methyltransferases in Trypanosoma brucei
por: Lott, Kaylen, et al.
Publicado: (2014)

Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
por: Shailesh, Harshita, et al.
Publicado: (2018)

Identification and Characterization of Protein Arginine Methyltransferase 1 in Acanthamoeba castellanii
por: Moon, Eun-Kyung, et al.
Publicado: (2017)

The macromolecular complexes of histones affect protein arginine methyltransferase activities
por: Fulton, Melody D., et al.
Publicado: (2021)

Activity and Function of the PRMT8 Protein Arginine Methyltransferase in Neurons
por: Dong, Rui, et al.
Publicado: (2021)

Structure, Activity and Function of the PRMT2 Protein Arginine Methyltransferase
por: Cura, Vincent, et al.
Publicado: (2021)

Protein Arginine Methyltransferase 5 Functions via Interacting Proteins
por: Liang, Zhenzhen, et al.
Publicado: (2021)

A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes
por: Iyamu, Iredia D., et al.
Publicado: (2021)

Protein arginine methyltransferases in renal development, injury, repair, and fibrosis
por: Yu, Jianjun, et al.
Publicado: (2023)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine
por: Hernandez, Juan E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_16n3iln9srslebqir05m507j4h